Invasive Devices Brings New Hope for Global Glucose Monitoring Devices Industry

The entire glucose monitoring device industry came to a standstill, when an ultra-slim graphene sensor was introduced to the healthcare industry. True to its name, this atom-thin patch can easily help control diabetes without using needles. Face behind this invention - Dae-Hyeong Kim and experts at the famous “Institute of Basic Sciences” as well as “Seoul National University” confirmed that the device is capable of delivering metformin. This drug is generally used in the treatment of diabetes through human skin to lower high level of blood-sugar. Device has been already tested on mice and has successfully detected glucose present in their sweat.

Research analysts at “Big Market Research “indicated that most glucose monitors sold so far, put patients through a painful ordeal of invasive process. Conventional sensors mainly work by pricking patient’s fingers several times in a day. They further tend to dab these devices with blood However, the advanced wearable glucose monitoring device can conveniently monitor an individual’s blood sugar level from his/her sweat in real time. Apart from this, this patch is connected a wireless power supply and sends accurate data through a state-of -the-art transmission unit. This characteristic enables the device preserve its original sensitivity even after several applications. Makers say this facilitates the application of the device for multiple treatments.

Commenting on the latest innovation, Dae-Hyeong said “One can easily replace the used microneedles with new ones. Treatment with Metformin through the skin is more efficient than that through the digestive system because the drug is directly introduced into metabolic circulation through the skin." Echoing his sentiments, he explained “These advances using nanomaterials and devices provide new opportunities for the treatment of chronic diseases like diabetes."

On the other words, this wearable GP – driven equipment is capable of not only of monitoring the sweat-based glucose level but also controlling the delivery of transcutaneous drug via temperature-responsive needles. This patch is placed on a human skin where the device starts on sweat generation. It takes approximately 15 minutes for the device to collect sweat before it reaches a RH more than 80 percent.

Eyeing the major developments in the industry, Big Market Research has added a report titled “Global Glucose Monitoring Devices Industry 2016 Deep Market Research Report.” Study weighs up on the major drivers, restraints and opportunities found responsible in shaping the future of the industry. Prominent vendors covered in research include Bayer Healthcare, Nipro, Terumo and Dexcom among many others. Stakeholders, product developers and marketing executives seeking data on industry performance across different regions would find the study worth their time and investment. To conclude, the report covers all the essential aspect beneficial for the business owners to make smarter decision and generate maximum ROI.


Suggested Articles

Plans include combining temperature readings with information related to cough sounds in an app.

Impact of WFH will be short-lived for purchases of PCs and tablets, IDC analyst believes

Critics also bemoan recent FAA decision to allow Boeing to re-certify 737 MAX